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a b s t r a c t
Endothelial cells present chemokines to T cells and can also stimulate the T cell antigen receptor by
presentation of peptide–MHC antigen complexes. This study was designed to investigate the potential
synergy between stimulation of the chemokine receptor CXCR3 and the human T cell receptor complex.
Transendothelial T cell migration towards CXCL10wasmodified by crosslinking CD3 immediately before
addition to the endothelium. When resting endothelium was used, T cells which had been activated
by crosslinking CD3 for only 1min showed a significant reduction (p<0.0001) in migration when com-
pared with untreated T cells. By contrast, endothelial cells which had been activated by stimulation with
interferon-g and tumour necrosis factor-a supported a specific increase in the migration of activated T
cells; this was most apparent after CD3 had been activated for 90min (p<0.0001). The molecular basis
for synergy between CXCR3 and the T cell receptor complexwas investigated bymeasurement of fluores-
cence resonance energy transfer. This showed that CXCL10 induced a close (<10nm) spatial association
between CXCR3 and the CD3« subunit on the cell-surface. These data demonstrate that stimulation of
both CXCR3 and the T cell receptor has the potential to enhance specifically both the proliferation and
extravasation of specific T cells during episodes of local inflammation.
© 2009 Elsevier Ltd. All rights reserved.
1. Introduction
Transendothelial migration of leucocytes from the blood into
sites of tissue inflammation is fundamental to the effective opera-
tion of the immune system. A multistep model for such migration
is now generally accepted (Adams and Shaw, 1994). Leukocytes
initially utilise relatively low affinity, selectin-mediated adhesion
to support shear-stress induced rolling contact with the luminal
surface of blood vessels. Subsequent encounter with inflamma-
tory chemokines induces integrin activation resulting in leukocyte
arrest. This is followed by cell flattening and the development of
processes which identify intercellular junctions that can support
diapedesis (Ley et al., 2007).
Integrin activation is mediated by the stimulation of G-protein
coupled receptorson the surfaceof leucocytesbyheparansulphate-
immobilised chemokines on the apical surface of endothelial cells
(Hardy et al., 2004). There is differential expression of chemokine
receptors by functional subsets of leukocyte (Campbell et al., 2003;
Satoet al., 2007), anddifferential chemokineexpressionwithin spe-
cific functional compartments and inflammatory sites. This permits
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the selective recruitment of appropriate immune cells to specific
locations.
Although appropriate for most leukocytes, the multistep model
takes no account of the antigen specificity of T cells. T cells recog-
nise cognate antigen via the T cell receptor (TCR) when it is
presented in the context of cell-surface MHC molecules by either
specialised or non-specialised antigen presenting cells (Huppa and
Davis, 2003). The ability of antigen recognition to influence T cell
motility and integrin-mediated adhesion has long been recognised
(Dustin and Springer, 1989; Epler et al., 2000), but the potential
for it to influence transendothelial migration remains a subject for
investigation.
Vascular endothelial cells express high levels of MHC class I and
variable levels of MHC class II; both of these can be increased by
inflammatory mediators such as IFNg (Shiao et al., 2007). These
cells can also take up protein antigens and process peptides for
presentation to specific T cell receptors in both classes ofMHC anti-
gen (Savage et al., 1995). Although human endothelial cells do not
express costimulatory B7 (CD80 or CD86)molecules, they are capa-
ble of inducing specific proliferation of CD4+ and CD8+ memory T
cells (Al-Lamki et al., 2008).
A range of studies in vitro have focused on the effect of cognate
antigen recognition on transendothelial T cell migration. Depend-
ingon theprecise systemused, the resultshavebeenvariable. Initial
studies suggested increased migration across endothelium which
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had been pre-treatedwith IFNg (Marelli-Berg et al., 1999; Tay et al.,
2003), whilst antigen-stimulated T cells were retained by resting
endothelium (Tay et al., 2003). These studies did not define a role
for chemokines in this system, although stimulation of endothe-
lial cells with IFNg is known to increase both the production (Sana
et al., 2005) and heparan sulphate-mediated capture (Carter et al.,
2003) of chemokines for apical presentation (Hardy et al., 2004) to
immune cells. In particular, the IFNg inducible chemokine CXCL10
is produced at a high level by activated endothelial cells (Luster and
Ravetch, 1987).
More recent studies of rapid T cell migration across activated
endothelial cells in the presence of shear-stresses, TCR stimulation
and chemokines have revealed further complexity. Stimulation of
theTCRwas shown to reduceCXCL10-drivenT cellmigration across
TNFa activated human umbilical vein endothelial cells (Manes
et al., 2007). However, TNFa stimulated dermal microvascular
endothelial cells supported enhanced T cell migration in the pres-
ence of TCR stimulation and the chemokine CX3CL1 (fractalkine),
which is expressed by TNFa stimulated microvascular endothelial
cells (ManesandPober, 2008).Amurinemodelhasprovided further
evidence of the importance of TCR stimulation for T cell migration
by demonstrating that insulin-specific CD8+ T cells require antigen
presentation by endothelial cells for efficient homing to pancreatic
islets (Savinov et al., 2003).
The potential for simultaneous chemokine receptor and T
cell receptor activation provides a basis to explain chemokine-
regulated transendothelial migration of antigen-specific T cells
(Ward and Marelli-Berg, 2009). The recent demonstration of a
CXCL12-dependent spatial association of CXCR4 with the TCR has
clear relevance for the integration of these signals. Indeed, it was
shown that CXCR4 canutilise immunoreceptor tyrosine-based acti-
vationmotifs (ITAMs) on components of the TCR complex for signal
transduction (Kumar et al., 2006). Such physical and functional
association may also allow TCR activation to influence chemokine
receptor signalling, with consequent enhancement or inhibition of
migration.Whilst the results of this study are of great interest, they
are of little relevance to the migration of T cells into inflammatory
sites as CXCR4 is predominantly involved inhomeostatic trafficking
of naïve T cells to lymph nodes (Campbell et al., 2003).
The chemokine receptor CXCR3 is upregulated on activated
T cells and plays a fundamental role in recruiting effector cells,
including Th1 cells during inflammatory processes such as allograft
rejection (Romagnani, 2005); indeed, CXCR3−/− mice are resis-
tant to acute cardiac allograft rejection (Hancock et al., 2000).
This chemokine receptor is activated by at least three inflam-
matory chemokines: CXCL9 (monokine induced by IFNg; MIG),
CXCL10 (IFNg-inducibleprotein; IP-10), andCXCL11 (IFN-inducible
T cell a-chemoattractant; I-TAC). A recent study has suggested
that, like activated CXCR4 (Kremer et al., 2003), ligand activation of
CXCR3 induces phosphorylation of the 70kD tyrosine kinase, Zeta-
associated protein (ZAP-70) which is also a critical component of
TCR signal transduction (Dar and Knechtle, 2007). Importantly, it
has been suggested that this provides a mechanism for cross-talk
between CXCR3 and the TCR, with activation of the TCR modulat-
ing thepotential for CXCR3-induced signalling, resulting in reduced
chemotaxis within a CXCL10 concentration gradient produced by
solute diffusion (Dar and Knechtle, 2007).
This study was designed to investigate further the regulation of
CXCL10-induced transendothelial migration of CXCR3-expressing
human T cells by defining the roles of endothelial cell activation
with proinflammatory cytokines with and without concurrent TCR
activation in the absence of B7-mediated costimulation. A series of
sensitive flow cytometric fluorescence resonance energy transfer
(FRET) experiments was then performed to examine the potential
for CXCL10 to induce a spatial association between CXCR3 and the
TCR complex.
2. Methods
2.1. EA.hy926 cells
The model human endothelial cell line EA.hy926 (Edgell et
al., 1983) was expanded in 75 cm2 tissue culture flasks (Corning,
UK) containing Dulbecco’s Modified EaglesMedium supplemented
with 10% FBS (both from Sigma, Poole, UK).
2.2. Activated T cells
Peripheral blood mononuclear cells were obtained by density
gradient centrifugation of heparinized blood samples taken from
healthy adult volunteers. Ficoll-Hypaque density gradient solution
(Amersham Biosciences, UK) was used, with mononuclear cells
being recovered from the interfacial layer following centrifugation
at 400g for 25min. These cells were then incubated horizontally in
75 cm2 flasks for 1h in RPMI1640 medium (Sigma) supplemented
with 10% FBS, after which the monocyte depleted peripheral blood
lymphocyte (PBL) population was recovered.
The PBL were activated and mitogenically expanded by incuba-
tion for 72h in 24-well plates which had previously been coated
with 1mg/ml of the monoclonal mouse anti-human CD3 antibody
OKT3 in PBS (IgG2a; Janssen-Cilag Ltd., UK). 3H-thymidine incor-
poration assays were performed in 96-well plates to assess PBL
proliferation in response to OKT3 and CXCL10. Bound and soluble
CXCL10 were contrasted for their ability to elicit proliferation by
first binding 10nM chemokine to the plate overnight with variable
quantities of OKT3, or by adding 10nMCXCL10 to themediumwith
the PBL. Following optimal 72h incubation, 1mCi 3H-thymidine
(Amersham Biosciences) was added to each well for 6h. Cells were
lysed, harvested onto a fibre glass filter mat, and b-scintillation
counting was performed (Microbeta; PerkinElmer, USA). The data
were analysed using Prism 3 software (Graphpad Software, USA).
2.3. CFSE staining
For some experiments, activated T cells were labelled with the
fluorescent intracellular dye carboxyfluorescein diacetate succin-
imidyl ester (CFSE). T cellswere suspended in serum free RPMI1640
mediumcontaininganoptimal concentrationof2.5mMCFSE (Invit-
rogen, UK) with agitation for 10min at room temperature. The
cells were then washed twice and resuspended in RPMI complete
medium,with satisfactory staining being confirmedbyflowcytom-
etry before the cells were used.
2.4. CD3 crosslinking prior to chemotaxis
To model the effects of cognate antigen recognition on the
endothelium, a system of CD3 crosslinking was used. Cells were
harvested 72h after initial mitogenic expansion by CD3 crosslink-
ing by plate-bound OKT3, washed and resuspended in medium
containing OKT3 at a concentration of 1mg/ml for 20min. The
cells were then washed and divided into two groups. The first was
labelled with CFSE as described above. The second was subjected
to crosslinking of CD3 by the addition of an Alexa 633-conjugated
goat anti-mouse IgG antibody (Invitrogen, UK). This secondary
crosslinking process was performed at a variety of different time
points before cells were washed and used in the chemotaxis assays
described below.
2.5. Phenotypic analysis by flow cytometry
Expressionof the chemokine receptor CXCR3by activatedT cells
was assessed by flow cytometric analysis following staining with
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a FITC-conjugated mouse anti-human CXCR3 antibody (R&D Sys-
tems, Abingdon, UK). The results were compared with those of
unstained cells and those of cells stained with a FITC-conjugated
IgG1 isotype control antibody (R&D Systems).
2.6. Chemotaxis assays and flow cytometric analysis of migrant T
cell populations
The migratory potential of activated T cells was assessed using
an in vitro model of transendothelial migration. EA.hy926 cells
were grown to confluence on 5mm pore polycarbonate mem-
branes (Transwell inserts; Corning Costar, UK) in 24-well plates.
For someexperiments confluentmonolayerswerepre-treatedwith
medium containing 100ng/ml TNFa and 100ng/ml IFNg (both
from R&D Systems) for 24h prior to the assay. A volume of 600ml
of RPMI1640 complete medium containing CXCL10 at a concen-
tration of 1 or 10nM was added to the lower chamber of each
well. A total of 1×106 activated T cells was then added above
the endothelial monolayer. To assess the effect of reactivation of
CD3, approximately equal numbers of CFSE labelled T cells (not
CD3 crosslinked) and Alexa 633 labelled (CD3 crosslinked) T cells
were added to the upper chamber of the well. After incubation
for 90min at 37 ◦C, migrant T cells were harvested from the lower
chamber.
Flow cytometric analysis allowed differentiation between the
CFSE labelled and Alexa 633 labelled T cell populations in cell sam-
ples added to the upper chamber and retrieved from the lower
chamber of the Transwell culture system. These cells were quan-
tified by reference to a known number of fluorescent spheres
(Flow Count; Beckman Coulter, UK) which were added to each
sample. The ratio of CFSE to Alexa 633 labelled cellswas then calcu-
lated and normalised relative to a 1:1 value for the pre-migration
cell population. Examination of the value for cells recovered from
the lower chamber allowed the effect of CD3 crosslinking on
the migratory ability of CXCL10 responsive T cells to be deter-
mined.
Additional experiments were performed in which the poly-
carbonate membranes were removed from the culture inserts at
various time points after addition of the T cells and fixed for exam-
ination by scanning laser confocal microscopy followed by X–Z
analysis of the image stack.
2.7. Fluorescence resonance energy transfer (FRET)
To investigate any possible interaction between the chemokine
receptor CXCR3 and the TCR complex, a flow cytometric FRET
assay was performed (Kumar et al., 2006). Activated T cells were
prepared as described above, some were incubated with 10nM
CXCL10 for 20min at 37 ◦C and then the cells were stained
withfluorochrome-conjugatedantibodies specific forCXCR3 (clone
49801, PE conjugate; R&D Systems) and CD3« (clone UCHT1, APC
conjugate; Becton Dickinson). The potential for FRET was assessed
by flow cytometry with excitation of CXCR3-PE at 488nm and
measurement of emission from CD3«-APC at 675nm. To demon-
strate that the FRETwas a non-random event both antibodies were
titrated to a saturating concentration as recommended by Batard et
al. (2002). Control experimentswere performed inwhich either the
incubation with CXCL10 was omitted, or anti-CD3 was substituted
with APC conjugated anti-CD45 antibodies as described previously
(Kumar et al., 2006). To determine whether any FRET detected was
occurring intracellularly following endocytosis of receptor com-
plexes, a 5min acid wash (20mM HCl/HBSS; pH 2) at 4 ◦C was
performed after CXCL10 stimulation to remove surface antibod-
ies. Identical assays were performed using conjugated antibodies
specific for CCR2 (clone 48607, PE conjugate; R&D Systems) and
CD3«, and the specific chemokine ligand CCL7. In all cases FRETwas
Fig. 1. Analysis of the function of CXCR3. Chemotactic migration of activated T cells
through an EA.hy926 endothelial cell monolayer towards various concentrations
of CXCL10. Prior activation of the endothelium with IFNg and TNFa increased the
number ofmigrant cells. Representative results are shown from one of three similar
assays; the bars show mean values± SEM.
examined and energy transfer efficiencies calculated as described
by Batard et al. (2002).
3. Results
3.1. Analysis of CXCR3 expression by activated T cells
Fig. 1 demonstrates that T cells activated for 72h by mitogenic
expansion by CD3 crosslinking are highly responsive to stimulation
of the chemokine receptor CXCR3; this receptor was not expressed
on freshly isolated T cells (not shown). Chemotaxis assays were
performed in the presence of CXCL10. Fig. 1 shows results from
experiments to optimise conditions for these assays. CXCL10 was
chemotactic for activated T cells, with subendothelial concentra-
tions as low as 1nM causing a statistically significant increase in
migration (p<0.001). A greater migratory response was produced
by 10nM CXCL10 but this was increased further by prior activation
of the endothelial monolayer with IFNg and TNFa (p=0.014).
Fig. 2. CXCR3 and CD3 activation have synergistic effects on T cell proliferation.
A range of OKT3 concentrations were bound to a 96-well plate overnight. 10nM
CXCL10 was also bound to the plate overnight (-H-), added in solution to the lym-
phocyte suspension (-N-), or controlled with PBS (--). The assay was incubated for
72h and T cell proliferation was determined by measuring 3H-thymidine incorpo-
ration. Representative results are shown from one of three similar assays; the bars
show mean values± SEM.
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Fig. 3. Validation of the transendothelial T cell migrationmodel. (A) Representative flow cytometric dotplots showing analysis of transendothelial chemotaxis assays. Region
P1 contains the total T cell population retrieved from the bottom chamber of a well following transendothelial migration. P2 contains the fluorosphere counting beads
added to the sample. P3 contains the Alexa 633 labelled T cells within P1. P4 contains the CFSE labelled T cells within P1. Enumeration of events in these regions allowed
the number of CFSE and Alexa 633 labelled cells to be calculated for analysis as described in Section 2. (B) Confocal microscopy showing the migration of T cells through
cytokine-stimulated endothelium. By separate use of lasers at 488nm and 633nmwavelengths it was possible to visualise CFSE labelled (untreated) T cells (green) and Alexa
633 labelled (CD3 crosslinked) T cells (red) in separate images. Overlaying these images allowed the spatial relationship of both cell populations to be compared at different
time points. The representative image was captured after 120min and shows an Alexa 633 labelled cell in the process of migration through the membrane, whilst CFSE
labelled cells remain on the surface of the endothelial cell monolayer. (For interpretation of the references to color in this figure legend, the reader is referred to the web
version of the article.)
3.2. CXCR3 and CD3 synergistically activate T cells
Crosslinking CD3 with immobilised OKT3 induces T cell acti-
vation and proliferation. A titration of OKT3 was performed with
and without the addition of CXCL10 to determine whether CXCR3
ligation alters the proliferative response after incubation for 72h.
Fig. 2 shows that addition of CXCL10 to the culture medium (solu-
ble CXCL10) resulted in a moderate increase in T cell proliferation
in the presence of a suboptimal concentration of OKT3; this was
increased further bybinding the chemokine to theplate.Non-linear
regression demonstrated that half-maximal T cell proliferation
was produced by 5ng/ml OKT3 in the absence of chemokine, but
this was reduced to 1.9ng/ml (p<0.05) in the presence of bound
CXCL10. The chemokine was not mitogenic in the absence of CD3
stimulation (data not shown).
3.3. Evaluation of a transendothelial chemotaxis assay using
activated T cells
Having found CXCL10 to be chemotactic for activated T cells,
experiments were performed to determine whether labelling with
the intracellular dye CFSE would adversely affect the migration of
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activated T cells. No significant difference (p=0.9) was observed
between transendothelialmigration of unstained and CFSE-stained
T cells towards 10nMCXCL10 (data not shown). Fig. 3A shows how
flow cytometric analysis of the migrant cell population was per-
formed. Themigrant cells (left panel, P1)weremixedwith a known
number of beads (left panel, P2) for counting. The cells were also
separated into CFSE positive cells (P4) and Alexa 633 positive cells
(P3) in order to assess the effect of crosslinking CD3 immediately
prior to performing the chemotaxis assay.
Scanning laser confocal microscopy was used to examine
migration of activated T cells through a cytokine-stimulated
endothelium. This technique alloweddirect visualisationofmigrat-
ing cells by X–Z cross-sectional analysis of the endothelial cell
monolayer and the Transwell membrane. Equal numbers of CFSE
labelled T cells and Alexa 633 labelled cells which had been reac-
tivated by CD3 crosslinking for 90min were applied at the start of
thechemotaxis assay. Fig. 3Bshows thedistributionofCFSE labelled
cells (green) and Alexa 633 labelled cells (red) in a filter sampled
120min after addition of the T cells. An Alexa 633 labelled cell can
be seen passing through the polycarbonatemembrane,whilst large
numbers of CFSE labelled cells remain on the apical surface of the
endothelium.
3.4. Transendothelial migration of activated T cells through
endothelial monolayers
Fig. 4 shows the results of experiments to determine the effect of
CD3 crosslinking on transendothelial migration of activated T cells
through endothelial monolayers towards CXCL10. Fig. 4A shows
results for resting endothelial cells. It can be seen that crosslink-
ing CD3 for 1min before the assay caused a significant reduction
in the migration of Alexa 633 labelled cells when compared to
the migration of the untreated, CFSE labelled cells. Interestingly,
this retardation of migration was only transient, with no signifi-
cant difference seen between the two T cell populations when CD3
crosslinking was performed 90min before the assay.
Fig. 4B shows the results of experiments using endothelial
monolayers which had been previously stimulated with IFNg and
TNFa. It can be seen that crosslinking CD3 for 1min before the
assay caused a statistically significant increase in the migration
of the Alexa 633 labelled cells when compared to the migration
of the untreated, CFSE labelled cells (p<0.01). This differential
migration became even more pronounced when CD3 crosslink-
ing was performed 90min before the assay (p<0.0001); after this
time the untreated T cells constituted only 25% of the migrant
population.
3.5. Demonstration of an association between CXCR3 and CD3 by
measuring FRET
Fig. 5 shows representative results fromexperimentsusing FRET
todemonstrateanassociationbetweenCXCR3andCD3«usinganti-
bodies conjugated respectivelywithPEandAPC (Batard et al., 2002;
Kumar et al., 2006). A positive FRET signal using this combination
of fluorophores is indicated when the efficiency of energy trans-
fer is greater than 1% (Batard et al., 2002). Fig. 5A shows that for a
given titration of the acceptor antibody (anti-CD3-APC) themedian
fluorescence intensity (MFI) of the FRET signal was insensitive to
increasing the concentration of donor antibody (anti-CXCR3-PE).
As sensitisation of the acceptor was measured, FRET efficiency
should be independent of donor concentration for a particular
acceptor concentration. This is because FRET efficiency is calculated
relative to the donor according as described by Batard et al. (2002).
Theabsenceof an increase inFRETefficiencyasdonorconcentration
increases is indicative of a positive FRET signal and indicates a close
(<10nm) association betweenCXCR3 andCD3. Importantly, an acid
Fig. 4. The effect of CD3 crosslinking on chemotaxis of activated T cells through
an endothelial monolayer. In both graphs, the bars indicate the proportion of Alexa
633 (crosslinked; filled bar) and CFSE labelled (untreated; open bar) T cells. (A)
Using resting endothelial cells. A significant reduction in the proportion of Alexa
633 labelled cells was seen in the migrant population, when CD3 crosslinking was
performed 1min before the assay. When CD3 crosslinking was carried out 90min
before the assay there was no significant change in the proportion of these cells
in the migrant population. (B) Using endothelial cells which had been previously
stimulatedwith IFNg and TNFa. Significant increases in the proportion of Alexa 633
labelled cells are seen in themigrant cell populations following CD3 crosslinking for
either 1min or 90min. In both cases representative results are shown from one of
three similar experiments; the bars show mean values± SEM.
wash reduced significantly this FRET signal (Fig. 5B), demonstrating
that this spatial association occurs on the T cell-surface.
In control experiments (Fig. 5B) no FRET was observed in the
absence of CXCL10 treatment, or when the cells were labelled
with appropriately conjugated antibodies specific for CXCR3 and
CD45. Further experiments also demonstrated the absence of FRET
between immunofluorescently labelled CD3« and CCR2 follow-
ing specific T cell stimulation with the specific ligand 10nM CCL7
(Fig. 5B).
4. Discussion
This studywasperformed toassessdownstreamfunctionsof the
potential synergy between signalling through CXCR3 and the TCR
onactivatedTcells. Initial studiesdemonstrated that restinghuman
T cells expressed little CXCR3, but this receptor was expressed
by the majority of T cells after mitogenic activation for 72h by
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Fig. 5. CXCR3 can be spatially associatedwith CD3. (A)Mean FRET efficiencies were
calculated for titrations of anti-CXCR3-PE and anti-CD3-APC demonstrating that
the FRET seen is non-random. Fluorescence intensity is expressed as a percent-
age of the maximal median fluorescence intensity (MFI). The increasing percentage
values corresponded to increasing anti-CD3« antibody concentrations. (B) Control
experiments demonstrated that the FRET signal is not due to non-specific spectral
overlap (CD45/CXCR3 control), is specific for CXCR3 (CCR2/CD3 control), is ligand-
dependent and is not entirely a consequence of receptor internalisation (reduction
following acid wash). The bars show mean values± SEM.
culturing with the immobilised CD3 antibody, OKT3. Indeed, pre-
vious studies have shown that CXCR3 is stored by resting T cells in
cytoplasmic granules allowing release onto the cell-surface within
minutes of activation (Gasser et al., 2006). This chemokine recep-
tor was shown to function in transendothelial chemotaxis assays
in which the ligand CXCL10 was added below the endothelial cell
monolayer. In these experiments it was found that activation of the
endothelial monolayer with the proinflammatory cytokines IFNg
and TNFa greatly increased the number of migrant cells. These
data are consistentwith previous studies showing increasedCXCR3
expression during T cell activation, with this receptor being most
highly expressed by memory and effector Th1 cells (Loetscher et
al., 1996).
The transendothelialmigration inducedby subendothelial addi-
tion of CXCL10 suggests recognition of this ligand on the apical
surface of the endothelial cells, where it may be bound and pre-
sented by heparan sulphate (Ranjbaran et al., 2006). The marked
increase in T cell migration observed across activated endothelium
is likely to be due to increased expression of a range of factors
(Sana et al., 2005). These include increased endothelial produc-
tion of additional chemokines such as CCL2 (Hardy et al., 2004),
the increased potential of modified heparan sulphate to bind and
present chemokines on the apical surface of the activated endothe-
lial cells (Carter et al., 2003), and increased expression of the critical
T cell adhesion molecules ICAM-1 and VCAM-1 (Alon and Ley,
2008).
The induction of T cell proliferation byOKT3 antibodies has been
well described and is a specific feature of this IgG2a monoclonal
CD3 antibody (Van Wauwe et al., 1980); the mitogenic activity is
produced by crosslinking the receptor complex. The current study
demonstrated that 50% maximal T cell proliferation was produced
by treatment of the culture wells with an antibody concentration
of approximately 5ng/ml, which is similar to the mitogenic con-
centration defined in earlier studies (Van Wauwe et al., 1980).
However, prior immobilisation of CXCL10 onto the culture wells
induced a similar rate of T cell proliferation in the presence of OKT3
at only 1.9ng/ml. This observation of CXCL10-mediated costim-
ulation is consistent with a previous study which demonstrated
that CXCR3 deficient T cells respond poorly in allogeneic mixed
leukocyte culture (Hancock et al., 2000).
It has been reported that stimulation with CXCL12 (Nanki and
Lipsky, 2000) or CCL5 (Bacon et al., 1995) will both enhance T cell
proliferation and cytokine production. Although the mechanism
for this chemokine-mediated costimulation remains incompletely
defined, it has been shown that both CXCR4 and CCR5 migrate to
the immune synapse following activation (Contento et al., 2008);
this is associated with reduced T cell migration allowing increased
contact with antigen presenting cells (Molon et al., 2005). It is also
known that stimulation with CXCL12 induces a spatial associa-
tion between CXCR4 and the TCR complex allowing the chemokine
receptor to activate components of the TCR signalling pathway
leading to increased CD69 and IL-2 production (Kumar et al., 2006).
A similar utilisation of the TCR signalling pathway has been shown
for CXCR3 (Dar and Knechtle, 2007).
An important validation experiment demonstrated that T cells
labelledwith CFSE showed a normal chemotactic response towards
CXCL10. This result is consistent with previous reports indicating
that limited concentrations of CFSE do not impair cell motility (De
Clercket al., 1994). A sensitiveflowcytometric assaywasdeveloped
to allowsimultaneous enumerationof T cellswhichhadbeeneither
activated with plate-bound OKT3 for 72h or activated for 72h and
then subjected to a further cycle of CD3 crosslinking to model B7-
deficient antigen presentation by endothelial cells (Al-Lamki et al.,
2008; Manes et al., 2007). Application of these techniques demon-
strated that CD3 activation for 1min before measuring chemotaxis
towards CXCL10 across a resting endothelial monolayer reduced
the migration of these cells in comparison with T cells which had
not been activated at the time of the assay. However, this retarda-
tion was transient as T cells which had been activated for 90min
before the assay showed an equal migration to cells which had not
been activated. This observation is consistentwith previous reports
that specific TCR activation can arrest T cell migration across non-
IFNg treated endothelial cellmonolayers by activation of Src family
tyrosine kinases (Manes et al., 2007).
Endothelial cell monolayers which have been pre-treated with
the proinflammatory cytokines IFNg and TNFa support greater
chemotactic responses. However, T cells which had been activated
by crosslinking CD3 for either 1min or 90min showed a further
increase in migration towards CXCL10 across activated endothe-
lium when compared with cells which had not been reactivated.
Indeed, T cells which had been reactivated for 90min before the
assay constituted almost 75% of the migrant population. Although
the basis for the difference in migration of reactivated T cells
across resting and activated endothelial cells is unclear, a previ-
ous report has noted that stimulation of endothelial cells with IFNg
can increase themigration of antigen-activated T cells by reversing
a “stop signal” (Tay et al., 2003). Studies performed in vivo have
also shown that IFNg is required for the homing of antigen-specific
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T cells during autoimmune diabetes (Savinov et al., 2001), with
endothelial presentationof autoantigenpromoting the recruitment
of specific T cells (Greening et al., 2003).
A series of experiments was performed to identify any change
in the spatial relationship between CXCR3 and CD3 following
chemokine treatment in order to identify a basis for the syn-
ergy observed between these receptors. An established flow
cytometric FRET assay was employed for this study using the
fluorochromes PE and APC, which transfer fluorescence energy
when they are separated by a distance of less than 10nm (Batard
et al., 2002). Treatment of activated T cells with 10nM CXCL10
markedly increased the fluorescence output due to FRET when
CXCR3 and CD3« were labelled with antibodies conjugated to
these fluorochromes. These data indicate for the first time a
ligand-dependent, spatial association between CXCR3 and the TCR
complex.
A similar increase inFRETwasnotobservedwhenthePEandAPC
fluorochromes were bound to CXCR3 and the common cell-surface
molecule CD45, indicating that the interaction between CXCR3 and
CD3« was induced specifically by CXCL10. Importantly, a brief acid
wash to remove cell-surface antibodies diminished the FRET signal
demonstrating that these receptors were spatially associated on
the cell-surface. The remaining, acid resistant FRET signal is indica-
tive of a potentially non-specific fluorochrome association within
the endosomal compartment following internalisation. These FRET
results are consistent with a previous demonstration that CXCL12
induces a physical association between CXCR4 and CD3 on the
surface of T cells (Kumar et al., 2006). However, ligand-induced
chemokine receptor associationwith the TCR complex is not a gen-
eral finding as treatment of the activated T cells with CCL7 did not
induce FRET between CCR2 and CD3«.
This study has shown that stimulation of CXCR3 on the sur-
face of activated T cells produces signals which can synergise with
those transduced by activation of the TCR complex. These signals
enhance both T cell proliferation and the specific migration of T
cells across cytokine-activated endothelium. The demonstration of
a chemokine ligand-induced spatial association between CXCR3
and CD3« is consistent with a previous demonstration that the
TCR and CXCR3 chemokine receptor signalling pathways share sig-
nal transduction molecules (Dar and Knechtle, 2007) and suggests
a mechanistic basis for the enhanced transendothelial migration
observed in this study.
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